Burning Rock Biotech Limited (BNR)

NASDAQ: BNR · USD

$12.2

+0.30 (+2.5%)· Recorded snapshot

Market cap	128.3M
Revenue (ttm)	73.7M
Net income (ttm)	-10M
EPS (ttm)	-$0.95
Shares out	10.5M
Volume	17,317
Beta	1.29

Market data

Price

Recent price action with selectable time range.

Financial snapshot

Revenue (ttm): 73.7M
Net income (ttm): -10M
EPS (ttm): -$0.95
Market cap: 128.3M

Ticker	Name	Market cap	P/E	P/S	ROIC	5Y rev CAGR	1Y total return	Rating
EXAS	Exact Sciences Corp	—	—	—	—	—	—	Aanhouden

Calendar

Next earnings

Upcoming earnings date and setup when available.

Upcoming

DateLoading

Window—

EPS estimate—

Revenue estimate—

Sector percentile context

Refreshed 2026-10-28 19:55 UTC

Forward P/En/a

P25 13.4P50 20.2P75 35.7

Trailing P/En/a

P25 15.4P50 25.8P75 43.5

ROE-12.8

P25 -113.8P50 -46.5P75 -0.9

ROIC-7.1

P25 -68.5P50 -27.1P75 1.8

Benchmarks · 1M

All BNR indicators

Market & fundamental data

Available fields

205

Groups with data

Currency

CNY

Showing 205 of 205 available metrics for this ticker.

Profile and market data

Ticker identity, listing, currency, market cap, and source dates.

Metric	Value
Amount currency	USD
CIK code	0001792267
Company name	Burning Rock Biotech Limited
Country	China
Country code	US
CUSIP number	12233L206
Earnings date	2026-11-19
Earnings time	bmo
Employees	667
Employees change	-7
Employees growth	-1.04%
Enterprise value	$73.6M
Exchange	NASDAQ
Financial currency	CNY
Financial report date	2026-06-30
First seen	2026-05-09
Fiscal year end	December
Founded	2014
Industry	Diagnostics & Research
IPO date	2020-06-12
Is primary listing	Yes
Is SPAC	No
ISIN number	US12233L2060
Last 10-K release date	2026-04-28
Last earnings date	2026-09-10
Last refreshed	2026-10-28
Last stock split date	2024-05-15
Last stock split type	Reverse
Market cap	$128.3M
Market cap category	Micro-Cap
Next earnings date	2026-11-19
Options	No
Price	$12.17
Price currency	USD
Sector	Healthcare
SIC code	8071
Stock price date	2026-10-28
Symbol	BNR
Website	https://www.brbiotech.com

Valuation

Multiples, yields, enterprise-value ratios, and valuation checks.

Metric	Value
Earnings yield	-7.77%
EV/Sales	0.96x
FCF / EV yield	-3.72%
FCF yield	-2.09%
Industry forward P/E	30.71x
Industry P/E	50.2x
P/B ratio	1.76x
P/S ratio	1.7x
Price / tangible book value	1.71x
Sector forward P/E	23.53x
Sector P/E	51.01x

Profitability

Margins, returns on capital, cash conversion, and quality metrics.

Metric	Value
EBIT margin	-12.99%
EBITDA margin	-11.64%
Gross margin	74.55%
Operating margin	-12.99%
Pretax margin	-13.27%
Profit margin	-13.59%
Profit per employee	$-15,014
Revenue per employee	$110,497
ROA	-5.16%
ROA (5Y)	-21.73%
ROCE	-12.2%
ROE	-12.82%
ROE (5Y)	-46.23%
ROIC	-7.09%
SBC / revenue	2.77%
Tax / revenue	0.32%

Growth

Revenue, earnings, cash-flow, and forward growth indicators.

Metric	Value
EPS growth years	3
Gross profit growth	-3.5%
Gross profit growth (Q)	-9.52%
Gross profit growth 3Y	-3.01%
Gross profit growth 5Y	0.84%
Net income growth years	3
Revenue growth	-6.65%
Revenue growth (Q)	-9.28%
Revenue growth (QoQ)	24.85%
Revenue growth 3Y	-5.09%
Revenue growth 5Y	0.45%
Revenue growth years	1

Financial statements

Income-statement and cash-flow amounts, totals and per share.

Metric	Value
Capital expenditures	$-787,370
Depreciation and amortization	$1M
EBIT	$-9.6M
EBITDA	$-8.6M
EPS	$-0.95
FCF per share	$-0.25
Financing cash flow	$-29,443
Free cash flow	$-2.6M
Free cash flow minus SBC	$-4.7M
Gross profit	$54.9M
Income taxes	$236,574
Investing cash flow	$-869,744
Net borrowing	$285,007
Net cash flow	$-5.3M
Net income	$-10M
Operating cash flow minus SBC	$-3.9M
Operating income	$-9.6M
Revenue	$73.7M
Stock-based compensation	$2M

Financial strength

Debt, cash, solvency, accounting-quality, and balance-sheet signals.

Metric	Value
Altman Z-Score	-4.18
Book value per share	$6.74
Debt / equity	0.09
Interest coverage	-1,083.57
Long-term assets	$10.9M
Long-term liabilities	$4.7M
Net cash (debt)	$54.7M
Net cash / market cap	43.71%
Net cash growth	-10.13%
Net debt / equity	-0.75
Piotroski F-Score	4
Property, plant and equipment	$11.7M
Shareholders' equity	$73.2M
Tangible book value	$73.1M
Tangible book value per share	$6.73
Total assets	$110.5M
Total cash	$61.4M
Total debt	$6.6M
Total liabilities	$37.3M
WACC	10.8%

Liquidity

Current-asset coverage and working-capital efficiency metrics.

Metric	Value
Asset turnover	0.64
Current assets	$99.6M
Current liabilities	$32.6M
Current ratio	3.05
Inventory turnover	2.77
Net working capital	$7.5M
Quick ratio	2.76
Working capital	$65.7M
Working capital turnover	0.15

Dividends and buybacks

Dividend yield, payout, buybacks, and shareholder-yield indicators.

Metric	Value
Buyback yield / dilution	-0.43%
Dividend yield	0%
Shareholder yield	-0.43%

Performance and technicals

Returns, volatility, beta, momentum, RSI, and moving-average context.

Metric	Value
150-day SMA	$12.96
1D price change	2.49%
1M price change	-33.84%
1M total return	-33.84%
1W price change	-2.8%
1W total return	-2.8%
1Y price change	5.17%
1Y return CAGR	5.18%
1Y total return	5.17%
20-day SMA	$14.10
200-day SMA	$16.60
3M price change	30.9%
3M total return	30.9%
3Y price change	16.64%
3Y return CAGR	5.26%
3Y total return	16.64%
50-day SMA	$13.19
50-day SMA vs 200-day SMA	50under200
52-week high	$41.72
52-week high date	2026-01-22
52-week low	$6.79
52-week low date	2026-06-17
5Y price change	-91.38%
5Y return CAGR	-38.76%
5Y total return	-91.38%
6M price change	-35.44%
6M total return	-35.44%
All-time high	$397.50
All-time high date	2021-02-22
All-time low	$2.18
All-time low date	2025-05-05
Average true range (ATR)	$1.63
Average volume	25.6K
Beta (1Y)	2.92
Beta (2Y)	2.25
Beta (5Y)	1.29
Change from 52-week high	-70.84%
Change from 52-week low	79.16%
Change from all-time high	-96.9%
Change from all-time low	464.45%
Change from open	5.87%
Day's gap	-3.2%
Dollar volume	$210,661
High price	$12.42
Low price	$11.49
Monthly RSI	46.41
Open price	$11.49
Position in 52-week range	72.58%
Previous close	$11.87
Price vs 150-day SMA	-5.05%
Price vs 20-day SMA	-12.74%
Price vs 200-day SMA	-25.89%
Price vs 50-day SMA	-6.7%
Relative volume	0.68
Return from IPO open	-94.79%
Return from IPO price	-28.06%
RSI	43.67
Sharpe ratio	0.55
Sharpe ratio (3Y)	0.57
Sharpe ratio (5Y)	-0.06
Sortino ratio	0.9
Sortino ratio (3Y)	0.97
Sortino ratio (5Y)	-0.04
Volume	17.3K
Weekly RSI	46.59
YTD price change	-38.93%
YTD total return	-38.93%

Ownership and float

Institutional, insider, float, short-interest, and share-count fields.

Metric	Value
Float	3.3M
Float percentage	31.46%
Shares change (QoQ)	3.24%
Shares change (YoY)	0.43%
Shares held by insiders	30.92%
Shares held by institutions	11.03%
Shares outstanding	10.5M
Short % of shares	0.58%
Short ratio	0.7 days

Deeper analysis on BNR

14 sections in the full report · jump straight to what you need

Forecast

Base and Bull forecast paths with report-date return framing.

→

Valuation

Fair-value bridge, DCF, owner earnings, and peer multiples.

→

Sensitivity

Cost-of-equity and terminal-growth stress table.

→

Risks

Kill scenarios, soft-pass flags, and downside catalysts.

→

Earnings

Next earnings setup and beat / inline / miss thresholds.

→

Position sizing

Entry, exit, conviction, and quarterly monitoring rules.

→

Financials

Revenue, margins, cash flow, and balance-sheet context.

→

Peers

Relative valuation and profitability against the cohort.

→

Moat

Economic-profit evidence and competitive advantage risk.

→

Industry cycle

Sector phase, capital cycle, and secular tailwinds.

→

Frequently asked questions

About this BNR report

Is a complete BNR research report available?

No complete published report is available for Burning Rock Biotech Limited (BNR) on this page. Market-directory data, when present, is not a substitute for a validated stock analysis.

Burning Rock Biotech Limited (BNR)

Price

Financial snapshot

Fair-value bridge

Latest news · BNR

Valuation

Profitability

Balance sheet

Trading

Next earnings

Sector percentile context

All BNR indicators

Profile and market data

Valuation

Profitability

Growth

Financial statements

Financial strength

Liquidity

Dividends and buybacks

Performance and technicals

Ownership and float

Deeper analysis on BNR

Frequently asked questions